Phenylpropanoids of plant origin as inhibitors of biofilm formation by Candida albicans

Journal of Microbiology and Biotechnology

Volumn 24, Issue 9, 2014, Pages 1216-1225

  Raut, Jayant Shankar ^a   Shinde, Ravikumar Bapurao ^a   Chauhan, Nitin Mahendra ^a   Karuppayil, Sankunny Mohan ^a  

^a SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

Antifungal; Bioactive compound; Biofilm; Candida albicans; Drug resistance; Phenylpropanoid

Indexed keywords

AMPHOTERICIN B; ANISALDEHYDE; ANISIC ACID; ANISYL ALCOHOL; ANTIFUNGAL AGENT; CAFFEIC ACID; CINNAMALDEHYDE; CINNAMIC ACID; CRYSTAL VIOLET; EUGENOL; FARNESOL; FERULIC ACID; FLUCONAZOLE; GUAIACOL; PHENYLPROPANOID DERIVATIVE; PLANT MEDICINAL PRODUCT; SALICYLALDEHYDE; SALICYLIC ACID; UNCLASSIFIED DRUG; VANILLIN; VIRULENCE FACTOR; PHENOL DERIVATIVE; PHENYLPROPIONIC ACID DERIVATIVE; PLANT EXTRACT;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL ADHESION; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG SCREENING; FUNGICIDAL ACTIVITY; FUNGUS HYPHAE; GROWTH INHIBITION; IN VITRO STUDY; METABOLIC ACTIVITY ASSAY; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; YEAST; ANTIFUNGAL RESISTANCE; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; HYPHAE; PHENOLS; PHENYLPROPIONATES; PLANT EXTRACTS;

EID: 84907963164     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1402.02056     Document Type: Article

References (36)

1. Betts JW, Haswell SJ. 2013. Antifungal synergy of theaflavin and epicatechin combinations against Candida albicans. J. Microbiol. Biotechnol. 23: 1322-1326.
2. Bink A, Pellens K, Cammue BPA, Thevissen K. 2011. Antibiofilm strategies: how to eradicate Candida biofilms? Open Mycol. J. 5: 29-38.
3. Camacho DP, Gasparetto A, Svidzinski TIE. 2007. The effect of chlorhexidine and gentian violet on the adherence of Candida spp. to urinary catheters. Mycopathologia 163: 261-266.
4. Campbell BC, Chan KL, Kim JH. 2013. Chemosensitization as a means to augment commercial antifungal agents. Front. Microbiol. 3.
5. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormic T, Ghannoum MA. 2001. Biofilm formation by fungal pathogen Candida albicans: development, architecture and drug resistance. J. Bacteriol. 183: 5385-5394.
6. Chauhan NM, Raut JS, Karuppayil SM. 2011. Acetaldehyde inhibits yeast to hyphal form morphogenesis and biofilm formation in Candida albicans. Mycoscience 52: 356-360.
7. Clatworthy AE, Pierson E, Hung DT. 2007. Targeting virulence: a new paradigm for antimicrobial therapy. Nature Chem. Biol. 3: 541-548.
8. Clifford MN. 1999. Chlorogenic acids and other cinnamates– nature, occurrence and dietary burden. J. Sci. Food Agric. 9: 362-372.
9. Clinical and Laboratory Standards Institute (CLSI). 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard, 2nd Ed. M27-A2. Wayne, PA.
10. Cuellar-Cruz M, Vega-Gonzalez A, Mendoza-Novelo B, Lopez-Romero E, Ruiz-Baca E, Quintanar-Escorza MA, et al. 2012. The effect of biomaterials and antifungals on biofilm formation by Candida species: a review. Eur. J. Clin. Microbiol. Infect Dis. 31: 2513-2527.
11. Darvishi E, Omidi M, Bushehri AAS, Golshani A, Smith ML. 2013. The antifungal eugenol perturbs dual aromatic and branched-chain amino acid permeases in the cytoplasmic membrane of yeast. PLoS One 8: e76028.
12. De Vita D, Friggeri L, D’Auria FD, Pandolfi F, Piccoli F, Panella S, et al. 2014. Activity of caffeic acid derivatives against Candida albicans biofilm. Bioorg. Med. Chem. Lett. 24: 1502-1505.
13. Ergun BC, Coban T, Onurdag FK, Banoglu E. 2011. Synthesis, antioxidant and antimicrobial evaluation of simple aromatic esters of ferulic acid. Arch. Pharm. Res. 34: 1251-1261.
14. Farber BF, Wolff AG. 1993. Salicylic acid prevents the adherence of bacteria and yeast to silastic catheters. J. Biomed. Mater. Res. 27: 599-602.
15. Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d’Enfert C. 2004. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell 3: 536-545.
16. He M, Du M, Fan M, Bian Z. 2007. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia 163: 137-143.
17. Hemaiswarya S, Doble M. 2010. Synergistic interaction of phenylpropanoids with antibiotics against bacteria. J. Med. Microbiol. 59: 1469-1476.
18. Hemaiswarya S, Soudaminikkutty R, Narasumani ML, Doble M. 2011. Phenylpropanoids inhibit protofilament formation of Escherichia coli cell division protein FtsZ. J. Med. Microbiol. 60: 1317-1325.
19. Ivanauskas L, Jakstas V, Radusiene J, Lukosius A, Baranauskas A. 2008. Evaluation of phenolic acids and phenylpropanoids in the crude drugs. Medicina 44: 48.
20. Kathiravan MK, Salake AB, Chothe AS, Dudhe PB, Watode RP, Mukta MS, et al. 2012. The biology and chemistry of antifungal agents: a review. Bioorg. Med. Chem. 20: 5678-5698.
21. Khan A, Ahmad A, Akhtar F, Yousuf S, Xess I, Khan LA, et al. 2011. Induction of oxidative stress as a possible mechanism of the antifungal action of three phenylpropanoids. FEMS Yeast Res. 11: 114-122.
22. Khan MSA, Ahmad I. 2012. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms. J. Antimicrob. Chemother. 67: 618-621.
23. Khodavandi A, Harmal NS, Alizadehd F, Scully OJ, Sidike SM, Othman F, et al. 2011. Comparison between allicin and fluconazole in Candida albicans biofilm inhibition and in suppression of HWP1 gene expression. Phytomedicine 19: 56-63.
24. Korkina LG. 2007. Phenylpropanoids as naturally occurring antioxidants: from plant defense to human health. Cell Mol. Biol. 53: 15-25.
25. LaFleur MD, Kumamoto CA, Lewis K. 2006. Candida albicans biofilms produce antifungal tolerant persister cells. Antimicrob. Agents Chemother. 50: 3839-3846.
26. Lee JH, Lee BK, Kim JH, Lee SH, Hong SK. 2009. Comparison of chemical compositions and antimicrobial activities of essential oils from three conifer trees; Pinus densiflora, Cryptomeria japonica, and Chamaecyparis obtusa. J. Microbiol. Biotechnol. 19: 391-396.
27. Nickerson KW, Atkin AL, Hornby JM. 2006. Quorum sensing in dimorphic fungi: farnesol and beyond. Appl. Environ. Microbiol. 72: 3805-3813.
28. Pauli A. 2006. Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med. Res. Rev. 26: 223-268.
29. Pfaller MA, Messer SA, Coffmann S. 1995. Comparison of visual and spectrophotometric method of MIC endpoint determinations by using microdilution methods to test five antifungal agents including the new triazole D0870. J. Clin. Microbiol. 33: 1094-1097.
30. Raut JS, Karuppayil SM. 2014. Bioprospecting of plant essential oils for medicinal uses, pp. 59-76. In Fulekar MH, Pathak B, Kale RK (eds.). Environment and Sustainable Development. Springer, India.
31. Raut JS, Shinde RB, Chauhan NM, Karuppayil SM. 2013. Terpenoids of plant origin inhibits morphogenesis, adhesion and biofilm formation by Candida albicans. Biofouling 29: 87-96.
32. Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Giannini MM. 2013. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol. 62: 10-24.
33. Shinde RB, Raut JS, Karuppayil MS. 2012. Biofilm formation by Candida albicans on various prosthetic materials and its fluconazole sensitivity: a kinetic study. Mycoscience 53: 220-226.
34. Sudbery PE. 2011. Growth of Candida albicans hyphae. Nat. Rev. Microbiol. 9: 737-748.
35. Sung WS, Lee DG. 2010. Antifungal action of chlorogenic acid against pathogenic fungi, mediated by membrane disruption. Pure Appl. Chem. 82: 219-226.
36. Zhao LX, Li DD, Hu DD, Hu GH, Yan L, Wang Y, et al. 2013. Effect of tetrandrine against Candida albicans biofilms. PLoS One 8: e79671.